Sec Form 13D Filing - Troendle August J. filing for Medpace Holdings Inc. (MEDP) - 2020-07-30

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

_____________________

SCHEDULE 13D

(Rule 13d-101)

_____________________

 

Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a)

 

Under the Securities Exchange Act of 1934

(Amendment No. 9)*

_____________________

 

Medpace Holdings, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

58506Q109

(CUSIP Number)

 

August J. Troendle

c/o Medpace Holdings, Inc.

5375 Medpace Way

Cincinnati, OH 45227

Tel: (513) 579-9911

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

July 28, 2020

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 


 

 

1

NAMES OF REPORTING PERSONS

August J. Troendle

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) (b)

3

SEC USE ONLY

4

SOURCE OF FUNDS

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)      

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH

7

SOLE VOTING POWER

616,643

8

SHARED VOTING POWER

7,327,558

9

SOLE DISPOSITIVE POWER

616,643

10

SHARED DISPOSITIVE POWER

7,327,558

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

8,680,437

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

24.0%

14

TYPE OF REPORTING PERSON

IN

 


 


 

1

NAMES OF REPORTING PERSONS

Medpace Investors, LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) (b)

3

SEC USE ONLY

4

SOURCE OF FUNDS

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)      

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

7,327,558

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

7,327,558

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

7,517,348

 

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

20.8%

14

TYPE OF REPORTING PERSON

OO (Limited liability company)

 


 


 

This Amendment No. 9 to the Schedule 13D (this “Amendment No. 9”) amends and supplements the Statement on Schedule 13D filed with the United States Securities and Exchange Commission on August 26, 2016, as amended by Amendment No. 1 filed on August 8, 2018, Amendment No. 2 filed on October 2, 2018, Amendment No. 3 filed on February 6, 2019, Amendment No. 4 filed on August 5, 2019, Amendment No. 5 filed on August 7, 2019, Amendment No. 6 filed on August 15, 2019, Amendment No. 7 filed on September 17, 2019 and Amendment No. 8 filed on May 8, 2020 (collectively, the “Statement”), relating to the common stock (the “Common Stock”), of Medpace Holdings, Inc., a Delaware corporation (the “Issuer”).   Capitalized terms used herein without definition shall have the meaning set forth in the Statement.

Item 4.Purpose of Transaction

Item 4 of the Statement is amended and supplemented by inserting the following information:

The responses to Items 5 and 6 of this Schedule 13D are incorporated herein by reference.

On March 4, 2020, Medpace Investors, LLC (“MPI”) entered into a written stock selling plan in accordance with Rule 10b5-1 (the “2020 MPI Plan”).

Item 5.Interest in Securities of the Issuer

Item 5 of the Statement is amended and restated in its entirety as follows:

(a) - (b): See Items 7 – 13 of the cover pages above.

(c): MPI sold 463,208 shares in open market transactions under the 2020 MPI Plan, as follows:

Trade Date

Shares Sold

Price Per Share

7/9/2020

2,455

$        100.15(1)

7/13/2020

5,503

$        100.43(2)

7/13/2020

624

$        101.13(3)

7/15/2020

573

$        101.74(4)

7/15/2020

3,634

$        103.37(5)

7/15/2020

4,876

$        104.27(6)

7/15/2020

15,230

$        105.26(7)

7/15/2020

4,387

$        106.01(8)

7/16/2020

14,356

$        103.64(9)

7/16/2020

917

$        104.61(10)

7/17/2020

2,774

$        103.90(11)

7/17/2020

7,501

$        105.23(12)

7/17/2020

9,034

$        105.82(13)

7/20/2020

7,647

$        105.05(14)

7/20/2020

10,088

$        105.78(15)

7/21/2020

5,999

$        106.03(16)

7/21/2020

20,016

$        106.93(17)

 


 

7/21/2020

2,075

$        107.48(18)

7/22/2020

641

$        107.17(19)

7/22/2020

3,001

$        108.93(20)

7/22/2020

12,796

$        109.62(21)

7/22/2020

17,680

$        110.42(22)

7/22/2020

1,760

$        111.14(23)

7/23/2020

11,297

$        110.42(24)

7/23/2020

5,302

$        111.37(25)

7/23/2020

4,913

$        112.35(26)

7/23/2020

9,606

$        113.34(27)

7/23/2020

625

$        114.00(28)

7/24/2020

27,158

$        105.93(29)

7/24/2020

6,245

$        106.58(30)

7/24/2020

684

$        108.10(31)

7/24/2020

293

$        110.04

7/27/2020

746

$        106.95(32)

7/27/2020

1,352

$        108.22(33)

7/27/2020

7,458

$        109.46(34)

7/27/2020

9,234

$        110.17(35)

7/27/2020

4,762

$        111.43(36)

7/27/2020

5,467

$        112.33(37)

7/28/2020

8,387

$        117.20(38)

7/28/2020

11,642

$        118.24(39)

7/28/2020

16,306

$        119.24(40)

7/28/2020

14,186

$        120.23(41)

7/28/2020

24,883

$        121.17(42)

7/28/2020

19,844

$        122.26(43)

7/28/2020

6,917

$        123.09(44)

7/28/2020

8,629

$        124.50(45)

7/28/2020

15,160

$        125.07(46)

7/28/2020

2,007

$        126.17(47)

7/28/2020

3,183

$        127.75(48)

7/28/2020

5,614

$        128.70(49)

7/28/2020

3,500

$        129.54(50)

7/28/2020

2,968

$        130.89(51)

7/28/2020

667

$        131.84(52)

7/28/2020

2,770

$        132.92(53)

7/28/2020

4,530

$        133.98(54)

7/28/2020

9,142

$        134.90(55)

7/28/2020

6,030

$        135.91(56)

7/28/2020

17,417

$        137.14(57)

7/28/2020

13,806

$        137.98(58)

7/28/2020

5,500

$        138.90(59)

7/28/2020

2,011

$        139.94(60)

 


 

7/28/2020

2,346

$        141.39(61)

7/28/2020

3,764

$        142.21(62)

7/28/2020

3,038

$        143.24(63)

7/28/2020

252

$        143.96(64)

 

(1) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.56. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(2) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.995. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(3) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.03 to $101.215. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(4) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.48 to $101.965. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(5) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.805 to $103.805. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(6) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.81 to $104.81. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(7) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.815 to $105.815. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(8) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.82 to $106.305. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(9) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.16 to $104.15. The Reporting Person undertakes to

 


 

provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(10) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.215 to $105.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(11) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.43 to $104.30. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(12) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.565 to $105.565. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(13) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.57 to $106.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(14) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.385 to $105.385. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(15) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.39 to $106.345. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(16) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.32 to $106.31. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(17) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.33 to $107.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(18) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.34 to $107.74. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

 


 

(19) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.89 to $107.78. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(20) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.05 to $109.05. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(21) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.055 to $110.05. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(22) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.06 to $111.06. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(23) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.065 to $111.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(24) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.82 to $110.815. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(25) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.845 to $111.84. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(26) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.86 to $112.85. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(27) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.915 to $113.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(28) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.95 to $114.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

 


 

(29) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.41 to $106.41. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(30) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.415 to $107.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(31) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.51 to $108.835. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(32) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.69 to $107.655. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(33) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.72 to $108.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(34) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.82 to $109.82. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(35) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.835 to $110.81. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(36) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.87 to $111.825. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(37) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.945 to $112.55. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upo n request.

(38) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.765 to $117.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

 


 

(39) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.67 to $118.67. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(40) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.675 to $119.675. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(41) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.70 to $120.695. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(42) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.705 to $121.675. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(43) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.72 to $122.71. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(44) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $122.725 to $123.69. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(45) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.735 to $124.73. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(46) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.74 to $125.69. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(47) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.745 to $126.715. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(48) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.22 to $128.215. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

 


 

(49) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.23 to $129.23. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(50) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.26 to $130.215. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(51) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.31 to $131.265. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(52) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.385 to $132.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(53) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.41 to $133.32. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(54) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.425 to $134.415. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(55) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.45 to $135.45. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(56) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.515 to $136.515. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(57) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.52 to $137.505. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(58) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.525 to $138.515. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

 


 

(59) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.53 to $139.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(60) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.54 to $140.52. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(61) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.755 to $141.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(62) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.76 to $142.685. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(63) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.885 to $143.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(64) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.94 to $143.965. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

(d): None.

(e): Not Applicable.

Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

Item 6 of the Statement is amended and supplemented as follows:

Item 4 above summarizes certain provisions of the 2020 MPI Plan and is incorporated herein by reference. A copy of the 2020 MPI Plan is attached as Exhibit 7 hereto, and is incorporated by reference.

Except as set forth herein and the Statement, none of the Reporting Persons or Related Persons has any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to any securities of the Issuer, including, but not limited to, any contracts, arrangements, understandings or relationships concerning the transfer or voting of such securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

 


 

Item 7.Materials to be Filed as Exhibits

Exhibit Number

 

Description

1

2

3

4

5

Joint Filing Agreement*

Voting Agreement*

Registration Rights Agreement*

Form of Lock-Up Agreement*

Rule 10b5-1 Stock Trading Plan of Medpace Investors, LLC dated August 20, 2018*

6

Rule 10b5-1 Stock Trading Plan of Medpace Investors, LLC dated November 15, 2018*

7

Rule 10b5-1 Stock Trading Plan of Medpace Investors, LLC dated March 4, 2020

 

*Filed in the Statement.


 


 

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: July 30, 2020

/s/ August J. Troendle

August J. Troendle

 

Medpace Investors, LLC

 

/s/ August J. Troendle

Name: August J. Troendle

Title:   Sole Manager